New China Life Insurance (HKG:1336, SHA:601336) expects a net profit attributable to shareholders between 24.0 billion yuan and 25.7 billion yuan for 2024, 175% to 195% higher than 8.71 billion yuan logged for 2023, a Monday Hong Kong bourse filing said.
The insurer attributed the expected surge in attributable profit to its timely investment in public equity and debt assets, increased operating structure and mechanism, and increased investment results from the market due to a series of favorable national policies.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。